Nova Patents
ES2654064T3

Immunopotentiative composition

Abstract

An inhibitor of the immunosuppressive PD-1 signal for use in the treatment of tumors, wherein the inhibitor of the immunosuppressive PD-1 signal is an anti-PD-L1 antibody.

ES2654064T3, drawing sheet 1
Sheet 1 of 17

Term

Term ended

Projected expiry passed 2 July 2023, 3.2 years ago.

  1. Priority
  2. Filed
  3. Projected expiry
  4. Published
  5. Today

17 sheets

  1. Sheet 1
  2. Sheet 2
  3. Sheet 3
  4. Sheet 4
  5. Sheet 5
  6. Sheet 6
  7. Sheet 7
  8. Sheet 8
  9. Sheet 9
  10. Sheet 10
  11. Sheet 11
  12. Sheet 12
  13. Sheet 13
  14. Sheet 14
  15. Sheet 15
  16. Sheet 16
  17. Sheet 17